AMBIT BIOSCIENCES CORP's ticker is AMBI and the CUSIP is 02318X100. A total of 15 filers reported holding AMBIT BIOSCIENCES CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $16,837,000 | +225.8% | 1,093,332 | +46.2% | 0.21% | +236.5% |
| Q2 2014 | $5,168,000 | -24.2% | 747,954 | 0.0% | 0.06% | -27.6% |
| Q1 2014 | $6,821,000 | -5.4% | 747,954 | 0.0% | 0.09% | -14.7% |
| Q4 2013 | $7,210,000 | -37.8% | 747,954 | -0.0% | 0.10% | -38.2% |
| Q3 2013 | $11,593,000 | +121.4% | 747,962 | 0.0% | 0.16% | +58.7% |
| Q2 2013 | $5,236,000 | – | 747,962 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JAY JEFFREY R | 1,000,000 | $7,000,000 | 5.53% |
| WEXFORD CAPITAL LP | 622,500 | $4,358,000 | 0.38% |
| Orbimed Advisors | 1,490,769 | $10,435,000 | 0.22% |
| Baker Brothers Advisors | 747,962 | $5,236,000 | 0.10% |
| STONERIDGE INVESTMENT PARTNERS LLC | 21,906 | $153,000 | 0.04% |
| Forward Management, LLC | 57,000 | $408,000 | 0.03% |
| Alyeska Investment Group, L.P. | 74,989 | $525,000 | 0.03% |
| Pine River Capital Management L.P. | 174,100 | $1,219,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 4,144 | $29,000 | 0.00% |
| FMR LLC | 802,250 | $5,616,000 | 0.00% |